M-CSF-specific monoclonal antibody and uses thereof
Details for Australian Patent Application No. 2005205533 (hide)
International Classifications
Event Publications
17 August 2006 PCT application entered the National Phase
PCT publication WO2005/068503 Priority application(s): WO2005/068503
24 April 2008 Assignment before Grant
Chiron Corpoartion ; Xoma Technology Ltd. The application has been assigned to Xoma Technology Ltd.; Novartis Vaccines and Diagnostics, Inc.
22 March 2012 Application Accepted
Published as AU-B-2005205533
19 July 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser